Evommune, Inc. (EVMN)
6.82
+0.51
(+8.08%)
USD |
NYSE |
Oct 29, 16:00
6.70
-0.12
(-1.76%)
After-Hours: 20:00
Evommune EPS Diluted (Quarterly) : -0.8924 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8924 |
| March 31, 2026 | -0.6437 |
| December 31, 2025 | -0.8969 |
| September 30, 2025 | -0.3957 |
| June 30, 2025 | -0.451 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.484 |
| September 30, 2024 | -0.5049 |
| June 30, 2024 | -0.9104 |
| March 31, 2024 | -0.0926 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.25M |
| Total Expenses (Quarterly) | 32.25M |
| Enterprise Value | 36.77M |
| Earnings Yield | -41.48% |
| Normalized Earnings Yield | -41.48 |